<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03286088</url>
  </required_header>
  <id_info>
    <org_study_id>ICBE-2-15217</org_study_id>
    <nct_id>NCT03286088</nct_id>
  </id_info>
  <brief_title>Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection</brief_title>
  <official_title>Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study primarily aims to collect standard of care clinical data in a wide spectrum of
      simple to complex mitral valve regurgitation (MVR) cases to validate a post-processing
      stand-alone software prototype (QFlow), developed by Philips Research Paris (Medisys).

      Investigator does not intervene in the care of the patient, but simply collects standard of
      care images and measurements that are needed for the validation of the investigational
      software.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Central diastolic and systolic blood pressures</measure>
    <time_frame>Day 1</time_frame>
    <description>images and measurements</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Mitral Valve Regurgitation of Any Grade</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>TransEsophageal Echocardiography + TransThoracic Echocardiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>TransEsophageal Echocardiography + TransThoracic Echocardiography + cardiac Magnetic Resonance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>TransEsophageal Echocardiography + TransThoracic Echocardiography + MitraClip</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>TransEsophageal Echocardiography and TransEsophageal Echocardiography</intervention_name>
    <description>imaging as standard practice</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiac Magnetics Resonance</intervention_name>
    <description>imaging as standard practice</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MitraClip</intervention_name>
    <description>imaging as standard practice</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both genders

          -  age between 18 and 85 years old (adult, senior)

          -  sinus rhythm

          -  hHemodynamic stable

          -  mitral valve regurgitation (MVR) of any grade i.e., from mild to severe as determined
             by assessment of a qualifying TransThoracic Echocardiography (TTE) exam at Saint-Luc
             University Hospital

          -  scheduled for TransEsophageal Echocardiography (TEE) at Saint-Luc University Hospital,
             as part of the subject's routine standard of care

          -  subjects has functional capacity to give written informed consent

        Exclusion Criteria:

          -  pregnancy

          -  subject lacks functional capacity to give written informed consent belongs to a
             vulnerable population per investigator's judgment or subject has any kind of disorder
             that compromises his/her ability to give written informed consent and/or to comply
             with study procedures

        Among the120 subjects, there will be three (3) sub-groups as follows:

          -  a first sub-group (A) of 50 subjects with all inclusion criteria and none of the
             exclusion criteria

          -  a second sub-group (B) of 50 subjects with additional inclusion criterion: scheduled
             for cardiac Magnetic Resonance (cMR), as part of the subject's routine standard of
             care

          -  a third sub-group (C) of 20 subjects with additional inclusion criterion: scheduled
             for MitraClip transcatheter mitral valve repair (MitraClip) procedure as part of the
             subject's routine standard of care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Saint Luc University Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernhard Gerber, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2017</study_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

